Thursday, March 28, 2024
Home Tags FibroGen

Tag: FibroGen

FibroGen Announces Topline Results from LELANTOS-1 Phase 3 Clinical Study of...

0
Study did not meet the primary endpointPamrevlumab was generally safe and well tolerated Topline results from LELANTOS-2 Phase 3 study of pamrevlumab in...

FGEN FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages FibroGen, Inc....

0
NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on...

0
NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against FibroGen,...

FGEN DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors...

0
RADNOR, Pa., June 04, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that...

FGEN Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders...

0
RADNOR, Pa., May 31, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that...

Investor Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors...

0
RADNOR, Pa. , May 23, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that...

HAGENS BERMAN Reminds FibroGen (FGEN) Investors of Securities Fraud Lawsuit and...

0
SAN FRANCISCO, May 23, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges FibroGen, Inc. (NASDAQ: FGEN) investors with significant losses to submit...

FIBROGEN DEADLINE ALERT: Faruqi & Faruqi LLP Securities Litigation Partner James...

0
NEW YORK, May 21, 2021 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential...

Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces...

0
RADNOR, Pa., May 15, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that securities...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their...

0
NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against FibroGen,...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News